Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
57.75
+0.31 (0.54%)
At close: Feb 21, 2025, 4:00 PM
56.89
-0.86 (-1.49%)
After-hours: Feb 21, 2025, 6:32 PM EST
Halozyme Therapeutics Operating Expense Breakdown
History
| Date | Selling, General, and Administrative | Cost of Sales | Research and Development | Amortization |
|---|---|---|---|---|
| Dec 31, 2024 | 154.34M | 159.42M | 79.05M | 71.05M |
| Sep 30, 2024 | 149.69M | 169.66M | 79.94M | 71.05M |
| Jun 30, 2024 | 143.72M | 175.06M | 78.81M | 73.63M |
| Mar 31, 2024 | 146.96M | 185.52M | 77.50M | 73.70M |
| Dec 31, 2023 | 149.18M | 192.36M | 76.36M | 73.77M |
| Sep 30, 2023 | 149.32M | 182.18M | 77.59M | 60.56M |
| Jun 30, 2023 | 148.52M | 174.68M | 76.98M | 67.42M |
| Mar 31, 2023 | 167.05M | 158.55M | 72.73M | 60.98M |
| Dec 31, 2022 | 143.53M | 139.30M | 66.61M | 43.15M |
| Sep 30, 2022 | 119.55M | 118.77M | 54.15M | 38.60M |
| Jun 30, 2022 | 98.25M | 90.04M | 45.93M | 11.40M |
| Mar 31, 2022 | 53.10M | 79.12M | 38.52M | - |
| Dec 31, 2021 | 50.32M | 81.41M | 35.67M | - |
| Sep 30, 2021 | 46.98M | 86.10M | 32.94M | - |
| Jun 30, 2021 | 45.51M | 73.08M | 32.21M | - |
| Mar 31, 2021 | 44.16M | 55.80M | 33.09M | - |
| Dec 31, 2020 | 45.74M | 43.37M | 34.24M | - |
| Sep 30, 2020 | 59.24M | 33.78M | 71.97M | - |
| Jun 30, 2020 | 65.52M | 50.55M | 94.68M | - |
| Mar 31, 2020 | 71.88M | 46.68M | 119.63M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.